Poster abstracts
3. Immunology

P31 Immunosuppression by IVIG is not mediated by T-cell apoptosis in MS
P32 Methylprednisolone treatment increases chemokine receptors expression in multiple sclerosis patients in relapse
P33 Different pattern of CD8+ T?lymphocytes in cerebrospinal fluid and whole blood of multiple sclerosis patients
P34 Serum antibodies to neurofilaments as marker for disease progression in multiple sclerosis
P35 Intracortical multiple sclerosis lesions are not associated with T?lymphocyte infiltration
P36 Cytokine flow cytometry in patients with multiple sclerosis (MS). An evolutive study
P37 Innate production of IL-10 and TNF and the risk of multiple sclerosis
P38 Role of lipid and oxidative metabolisms in patients at the onset of multiple sclerosis
P39 Expansion of a T-cell clone reactive to MBP 84-102 epitope in the peripheral blood and in the CSF of a HLA-DR2 multiple sclerosis patient
P40 Biased usage of TCR Vb5.2/5.3 by T?cells in the CSF and among PBMC with spontaneous and MBP 80-102 induced IFN-g expression in MS patients
P41 a-Galactosyl ceramide delays the onset of MOG 35-55-induced EAE in C57BL/6 mice
P42 Modulation of apoptosis in MS under therapy with interferon (IFN)-b1A
P43 Expanded T?cell clones in the CSF of MS patients correspond to PBL T? cells reactive with multiple antigens
P44 Immunoglobulin isotype patterns in multiple sclerosis patients indicate a predominant role of type?1 immunity in pathogenesis and progression
P45 Clinical aspects, fine specificity and pathogenicity of anti-MOG-autoantibodies in multiple sclerosis
P46 Immunohistology and cytokine mRNA expression in interferon-beta?1b induced skin lesions of patients with multiple sclerosis
P47 Active MRI lesion appearance in multiple sclerosis patients is associated with a decrease in circulating interferon-g and interleukin-4 producing T-cells
P48 Correlation of adhesion molecules in blood with disease burden in multiple sclerosis assessed by cranial MRI imaging
P49 Long term effects of interferon-beta-1b-therapy on c-ICAM-1 and -3
P50 Selective in vivo depletion of TCR Vb5.2/5.3 T?cells in MS patients reduces IFN-g mRNA expression and MBP 80-102 reactive T?cells
P51 T?cell anergy induced with DNA vaccination in EAE
P52 Disturbances in TNF receptor shedding as a model of cytokine dysregulation in MS
P53 Immunomodulation by IFN-b does not involve activation-induced T?cell death (AICD)
P54 Expression and function of the TRAIL system in human brain and autoreactive T?cells -?implications for multiple sclerosis
P55 Modulation of soluble CD95 in MS patients by interferon-b 1A therapy (Rebif?/master-study)
P56 Defective T?cell Fas function in patients with multiple sclerosis
P57 Antibodies against citrullinated myelin basic protein in serum and cerebrospinal fluid of multiple sclerosis (MS) patients
P58 Cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis
P59 The idiotypic network controls specific IgG reactivity of autoantibodies in multiple sclerosis (MS)
P60 Increased percentage of IL10 secreting CD14 cells in acute and of apoptotic T?cells in stable MS patients
P61 Effects of mitoxantrone on multiple sclerosis patient's lymphocyte subpopulations, immunoglobulin and cytokine production
P62 Induction of tolerance to Lewis Rat Experimental Autoimmune Neuritis (EAN) by an oligomerized T-cell epitope
P63 Abnormal a2-macroglobulin purified from patients with multiple sclerosis (MS)
P64 Analysis of 14-3-3 protein in the CSF as predictor of severity of multiple sclerosis (MS)
P65 Serum-Ciliary-Neurotrophic-Factor in multiple sclerosis
P66 Interleukin-6 in the cerebrospinal fluid from patients with multiple sclerosis
P67 IL-18-mediated modulation of matrix metallo-proteinases (MMPS) expression in monocytes: implications to multiple sclerosis (MS)
P68 Cell-bound-CD11 and CD31 in patients with relapsing-remitting and primary progressive multiple sclerosis
P69 Expression of TGFb-1, TNFa and their receptors in blood and CSF cells of MS-patients
P70 Cerebrospinal fluid concentrations of TGFb1,b2 are correlated with clinical and MRI markers in multiple sclerosis
P71 A new series of monoclonal antibodies to distinguish physiological stages of microglia
P72 Oncostatin M (OSM) - a novel cytokine involved in the immunopathology of multiple sclerosis (MS)
P73 Myelin-specific autoantibodies in X-linked adrenoleukodystrophy and multiple sclerosis
P74 Changes of serum RANTES induced by acute exacerbation and IFNb-1b treatment in relapsing-remitting multiple sclerosis
P75 Soluble interleukin-6 receptor (sIL-6R) levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
P76 Characterization of CD8 T lymphcytes and NK and NKT cells in multiple sclerosis patients during a relapse
P77 Phenotypic analysis of lymphocytes bearing NK receptors in multiple sclerosis
P78 Interferon-g producing V?2+?T?cells in multiple sclerosis: follow-up of relapsing remitting patients
P79 High numbers of activated dentritic cells in blood and cerebrospinal fluid of multiple sclerosis patients
P80 Treatment with IFN-b decreases the cellular proliferation and IL2 production modifying the CD28/CTLA-4 signal
P81 Propagation of rat bone marrow derived dendritic cells at different maturation stages -?implication for new therapeutic approaches in autoimmune disease models
P82 Is MxA protein a biological marker of viral presence in multiple sclerosis?
P83 Monitoring therapeutic efficacy in multiple sclerosis: an in vitro approach utilising a commercially available test
P84 Decreased percentage of peripheral blood CD56+CD16+ and increase of CD3+CD25+ and CD14+CD86+ percentage in multiple sclerosis patients treated with interferon?b-1A
P85 No evidence of CNS infection with Chlamydya pneumoniae in patients with multiple sclerosis (MS)
P86 The serum levels of interleukin-1 in primary and secondary chronic progressive course of multiple sclerosis

CONGRES ECTRIMS
6 - 9 septembre 2000
Toulouse

Retour au sommaire
 Lectures
Orals
Posters
Recherche par nom d'auteur
MASSON EDITEUR